Rapid diagnosis of Capnocytophaga canimorsus septic shock in an immunocompetent individual using real-time Nanopore sequencing: a case report.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
24 Jul 2019
Historique:
received: 11 12 2018
accepted: 07 06 2019
entrez: 26 7 2019
pubmed: 26 7 2019
medline: 8 10 2019
Statut: epublish

Résumé

Rapid diagnosis and appropriate treatment is imperative in bacterial sepsis due increasing risk of mortality with every hour without appropriate antibiotic therapy. Atypical infections with fastidious organisms may take more than 4 days to diagnose leading to calls for improved methods for rapidly diagnosing sepsis. Capnocytophaga canimorsus is a slow-growing, fastidious gram-negative bacillus which is a common commensal within the mouths of dogs, but rarely cause infections in humans. C. canimorsus sepsis risk factors include immunosuppression, alcoholism and elderly age. Here we report on the application of emerging nanopore sequencing methods to rapidly diagnose an atypical case of C. canimorsus septic shock. A 62 year-old female patient was admitted to an intensive care unit with septic shock and multi-organ failure six days after a reported dog bite. Blood cultures were unable to detect a pathogen after 3 days despite observed intracellular bacilli on blood smears. Real-time nanopore sequencing was subsequently employed on whole blood to detect Capnocytophaga canimorsus in 19 h. The patient was not immunocompromised and did not have any other known risk factors. Whole-genome sequencing of clinical sample and of the offending dog's oral swabs showed near-identical C. canimorsus genomes. The patient responded to antibiotic treatment and was discharged from hospital 31 days after admission. Use of real-time nanopore sequencing reduced the time-to-diagnosis of Capnocytophaga canimorsus in this case from 6.25 days to 19 h. Capnocytophaga canimorsus should be considered in cases of suspected sepsis involving cat or dog contact, irrespective of the patient's known risk factors.

Sections du résumé

BACKGROUND BACKGROUND
Rapid diagnosis and appropriate treatment is imperative in bacterial sepsis due increasing risk of mortality with every hour without appropriate antibiotic therapy. Atypical infections with fastidious organisms may take more than 4 days to diagnose leading to calls for improved methods for rapidly diagnosing sepsis. Capnocytophaga canimorsus is a slow-growing, fastidious gram-negative bacillus which is a common commensal within the mouths of dogs, but rarely cause infections in humans. C. canimorsus sepsis risk factors include immunosuppression, alcoholism and elderly age. Here we report on the application of emerging nanopore sequencing methods to rapidly diagnose an atypical case of C. canimorsus septic shock.
CASE PRESENTATION METHODS
A 62 year-old female patient was admitted to an intensive care unit with septic shock and multi-organ failure six days after a reported dog bite. Blood cultures were unable to detect a pathogen after 3 days despite observed intracellular bacilli on blood smears. Real-time nanopore sequencing was subsequently employed on whole blood to detect Capnocytophaga canimorsus in 19 h. The patient was not immunocompromised and did not have any other known risk factors. Whole-genome sequencing of clinical sample and of the offending dog's oral swabs showed near-identical C. canimorsus genomes. The patient responded to antibiotic treatment and was discharged from hospital 31 days after admission.
CONCLUSIONS CONCLUSIONS
Use of real-time nanopore sequencing reduced the time-to-diagnosis of Capnocytophaga canimorsus in this case from 6.25 days to 19 h. Capnocytophaga canimorsus should be considered in cases of suspected sepsis involving cat or dog contact, irrespective of the patient's known risk factors.

Identifiants

pubmed: 31340776
doi: 10.1186/s12879-019-4173-2
pii: 10.1186/s12879-019-4173-2
pmc: PMC6657077
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

660

Subventions

Organisme : Advance Queensland
ID : partnerships16-231
Organisme : Advance Queensland
ID : partnerships16-231
Organisme : Advance Queensland
ID : partnerships16-231

Références

Clin Microbiol Rev. 2001 Jan;14(1):177-207
pubmed: 11148009
BMC Res Notes. 2012 Dec 26;5:695
pubmed: 23267527
BMJ Case Rep. 2013 Jan 11;2013:null
pubmed: 23314879
J Infect Chemother. 2015 Mar;21(3):215-7
pubmed: 25445385
Eur J Clin Microbiol Infect Dis. 2015 Jul;34(7):1271-80
pubmed: 25828064
Genome Med. 2015 Sep 29;7:99
pubmed: 26416663
PLoS One. 2016 May 26;11(5):e0156299
pubmed: 27228001
Acta Anaesthesiol Scand. 2016 Nov;60(10):1437-1443
pubmed: 27251795
BMJ Case Rep. 2016 Jun 30;2016:
pubmed: 27364692
J Clin Microbiol. 2017 Jun;55(6):1902-1914
pubmed: 28381610
Expert Rev Anti Infect Ther. 2017 Oct;15(10):925-934
pubmed: 28918656
J Emerg Med. 2018 Jun;54(6):871-875
pubmed: 29523423
Int J Surg Case Rep. 2019;55:230-232
pubmed: 30776586
Clin Infect Dis. 2018 Sep 14;67(7):1139-1141
pubmed: 30986294

Auteurs

Seweryn Bialasiewicz (S)

Centre for Children's Health Research, Children's Health Queensland, 62 Graham St., South Brisbane, QLD, 4101, Australia. seweryn@uq.edu.au.
Child Health Research Centre, The University of Queensland, 62 Graham St., South Brisbane, QLD, 4101, Australia. seweryn@uq.edu.au.

Tania P S Duarte (TPS)

Institute for Molecular Bioscience, The University of Queensland, 306 Carmody Rd, St Lucia, QLD, 4072, Australia.

Son H Nguyen (SH)

Institute for Molecular Bioscience, The University of Queensland, 306 Carmody Rd, St Lucia, QLD, 4072, Australia.

Vichitra Sukumaran (V)

Infectious Diseases Unit Royal Brisbane and Women's Hospital, Level 6, Joyce Tweddell Building, Royal Brisbane and Women's Hospital, Brisbane, QLD, 4029, Australia.

Alexandra Stewart (A)

Infectious Diseases Unit Royal Brisbane and Women's Hospital, Level 6, Joyce Tweddell Building, Royal Brisbane and Women's Hospital, Brisbane, QLD, 4029, Australia.

Sally Appleton (S)

QML Pathology, PO Box 2280, Mansfield, QLD, 4122, Australia.

Miranda E Pitt (ME)

Institute for Molecular Bioscience, The University of Queensland, 306 Carmody Rd, St Lucia, QLD, 4072, Australia.

Arnold Bainomugisa (A)

Institute for Molecular Bioscience, The University of Queensland, 306 Carmody Rd, St Lucia, QLD, 4072, Australia.

Amy V Jennison (AV)

Forensic and Scientific Services, Queensland Department of Health, 39 Kessels Rd, Coopers Plains, QLD, 4108, Australia.

Rikki Graham (R)

Forensic and Scientific Services, Queensland Department of Health, 39 Kessels Rd, Coopers Plains, QLD, 4108, Australia.

Lachlan J M Coin (LJM)

Institute for Molecular Bioscience, The University of Queensland, 306 Carmody Rd, St Lucia, QLD, 4072, Australia.

Krispin Hajkowicz (K)

Infectious Diseases Unit Royal Brisbane and Women's Hospital, Level 6, Joyce Tweddell Building, Royal Brisbane and Women's Hospital, Brisbane, QLD, 4029, Australia.
School of Clinical Medicine, University of Queensland Level 6, Oral Health Centre, (883) 288 Herston Road, Herston, QLD, 4006, Australia.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH